FDA deems ResMed's respiratory device recall as most severe

FILE PHOTO: Signage is seen outside of FDA headquarters in White Oak, Maryland

The U.S. Food and Drug Administration (FDA) has recently identified the recall of ResMed's respiratory devices as the most serious recall in the medical device industry. This announcement has raised concerns among healthcare providers and patients who rely on these devices for respiratory support.

ResMed, a global leader in sleep apnea and respiratory care solutions, has initiated a voluntary recall of several of its ventilators and CPAP machines. The affected devices include the Astral 100 and 150 ventilators, as well as the Lumis 100 VPAP ST-A and Lumis 150 VPAP ST ventilatory support devices.